메뉴 건너뛰기




Volumn 16, Issue 4, 2016, Pages 383-386

Issues in biomarker identification, validation and development for disease diagnostics in Public Health

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

EID: 84955066763     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.2016.1133300     Document Type: Editorial
Times cited : (7)

References (20)
  • 1
    • 84933530147 scopus 로고    scopus 로고
    • Current status and future prospects of point-of care testing around the globe
    • Abel G. Current status and future prospects of point-of care testing around the globe. Expert Rev Mol Diagn. 2015; 15: 853-855.
    • (2015) Expert Rev Mol Diagn , vol.15 , pp. 853-855
    • Abel, G.1
  • 2
    • 53449095790 scopus 로고    scopus 로고
    • Over - The-counter biosensors: Past present and future
    • Lee T. Over-the-Counter Biosensors: Past, Present, and Future. Sensors. 2008; 8 (9): 5535-5559.
    • (2008) Sensors , vol.8 , Issue.9 , pp. 5535-5559
    • Lee, T.1
  • 3
    • 84944312514 scopus 로고    scopus 로고
    • Point-of- care diagnostics in low resource settings: Present status and future role of microfluidics
    • Sharma S, Zapatero-Rodríguez J, Estrela P, et al. Point-of- Care Diagnostics in Low Resource Settings: Present Status and Future Role of Microfluidics. Biosensors (Basel). 2015; 5 (3): 577-601.
    • (2015) Biosensors (Basel) , vol.5 , Issue.3 , pp. 577-601
    • Sharma, S.1    Zapatero-Rodríguez, J.2    Estrela, P.3
  • 4
    • 84878101085 scopus 로고    scopus 로고
    • Paper-based microfluidic point-of-care diagnostic devices
    • Yetisen AK, Akram MS, Lowe CR. Paper-based microfluidic point-of-care diagnostic devices. Lab Chip. 2013; 13 (12): 2210-2251.
    • (2013) Lab Chip , vol.13 , Issue.12 , pp. 2210-2251
    • Yetisen, A.K.1    Akram, M.S.2    Lowe, C.R.3
  • 5
    • 84893939933 scopus 로고    scopus 로고
    • Paper-based analytical devices for point-of care infectious disease testing
    • Rozand C. Paper-based analytical devices for point-ofcare infectious disease testing. Eur J Clin Microbiol Infect Dis. 2014; 33 (2): 147-156.
    • (2014) Eur J Clin Microbiol Infect Dis , vol.33 , Issue.2 , pp. 147-156
    • Rozand, C.1
  • 6
    • 84878694979 scopus 로고    scopus 로고
    • Point-of-care testing and the control of infectious diseases
    • Mohd Hanafiah K, Garcia M, Anderson D. Point-of-care testing and the control of infectious diseases. Biomark Med. 2013; 7 (3): 333-347.
    • (2013) Biomark Med , vol.7 , Issue.3 , pp. 333-347
    • Mohd Hanafiah, K.1    Garcia, M.2    Anderson, D.3
  • 7
    • 84944754759 scopus 로고    scopus 로고
    • Integrated analyses of gene expression profiles digs out common markers for rheumatic diseases
    • Wang L, Wu L-F, Lu X, et al. Integrated Analyses of Gene Expression Profiles Digs out Common Markers for Rheumatic Diseases. PLoS One. 2015; 10 (9): e0137522.
    • (2015) PLoS One , vol.10 , Issue.9 , pp. e0137522
    • Wang, L.1    Wu, L.-F.2    Lu, X.3
  • 8
    • 84941366394 scopus 로고    scopus 로고
    • Convergent genetic and expression datasets highlight TREM2 in Parkinson's disease susceptibility [Internet]
    • [cited 2016 Jan 11]
    • Liu G, Liu Y, Jiang Q, et al., et al. Convergent Genetic and Expression Datasets Highlight TREM2 in Parkinson's Disease Susceptibility [Internet]. Mol Neurobiol. 2015; 1-8. [cited 2016 Jan 11]. Available at http://link.springer.com/article/10.1007/s12035-015-9416-7/fulltext.html
    • (2015) Mol Neurobiol , pp. 1-8
    • Liu, G.1    Liu, Y.2    Jiang, Q.3    Et, Al. E.4
  • 9
    • 84940564438 scopus 로고    scopus 로고
    • Detecting cancer biomarkers in blood: Challenges for new molecular diagnostic and point-of-care tests using cell-free nucleic acids
    • Lewis JM, Heineck DP, Heller MJ. Detecting cancer biomarkers in blood: challenges for new molecular diagnostic and point-of-care tests using cell-free nucleic acids. Expert Rev Mol Diagn. 2015; 15 (9): 1187-1200.
    • (2015) Expert Rev Mol Diagn , vol.15 , Issue.9 , pp. 1187-1200
    • Lewis, J.M.1    Heineck, D.P.2    Heller, M.J.3
  • 10
    • 84942368641 scopus 로고    scopus 로고
    • CX3CR1 is dysregulated in blood and brain from schizophrenia patients
    • Bergon A, Belzeaux R, Comte M, et al. CX3CR1 is dysregulated in blood and brain from schizophrenia patients. Schizophr Res. 2015; 168: 434-443.
    • (2015) Schizophr Res , vol.168 , pp. 434-443
    • Bergon, A.1    Belzeaux, R.2    Comte, M.3
  • 11
    • 84940490759 scopus 로고    scopus 로고
    • What was old is new again: Using the host response to diagnose infectious disease
    • Ko ER, Yang WE, McClain MT, et al. What was old is new again: using the host response to diagnose infectious disease. Expert Rev Mol Diagn. 2015; 15: 1143-1158.
    • (2015) Expert Rev Mol Diagn , vol.15 , pp. 1143-1158
    • Ko, E.R.1    Yang, W.E.2    McClain, M.T.3
  • 13
    • 84885064636 scopus 로고    scopus 로고
    • Clinical application of sepsis biomarkers
    • Sankar V, Webster NR. Clinical application of sepsis biomarkers. J Anesth. 2013; 27: 269-283.
    • (2013) J Anesth , vol.27 , pp. 269-283
    • Sankar, V.1    Webster, N.R.2
  • 14
    • 77956628404 scopus 로고    scopus 로고
    • Sepsis biomarkers: A review
    • Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care. 2010; 14: R15.
    • (2010) Crit Care , vol.14 , pp. R15
    • Pierrakos, C.1    Vincent, J.L.2
  • 15
    • 84864199718 scopus 로고    scopus 로고
    • Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients
    • Layios N, Lambermont B, Canivet JL, et al. Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Crit Care Med. 2012; 40: 2304-2309.
    • (2012) Crit Care Med , vol.40 , pp. 2304-2309
    • Layios, N.1    Lambermont, B.2    Canivet, J.L.3
  • 16
    • 84896595576 scopus 로고    scopus 로고
    • A multibiomarkerbased outcome risk stratification model for adult septic shock
    • Wong HR, Lindsell CJ, Pettila V, et al. A multibiomarkerbased outcome risk stratification model for adult septic shock. Crit Care Med. 2014; 42: 781-789.
    • (2014) Crit Care Med , vol.42 , pp. 781-789
    • Wong, H.R.1    Lindsell, C.J.2    Pettila, V.3
  • 18
    • 84958169324 scopus 로고    scopus 로고
    • Biomarker development, from bench to bedside [Internet]
    • [cited 2016 Jan 11]
    • Stenman UH. Biomarker development, from bench to bedside [Internet]. Crit Rev Clin Lab Sci. 2015; 1-18. [cited 2016 Jan 11]. Available at http://www.tandfon line.com/doi/abs/10.3109/10408363.2015.1075468? journalCode=ilab20
    • (2015) Crit Rev Clin Lab Sci , pp. 1-18
    • Stenman, U.H.1
  • 19
    • 84961939914 scopus 로고    scopus 로고
    • Microarray meta-analysis and cross-platform normalization: Integrative genomics for robust biomarker discovery
    • Walsh C, Hu P, Batt J, et al. Microarray Meta-Analysis and Cross-Platform Normalization: Integrative Genomics for Robust Biomarker Discovery.Microarrays. 2015; 4 (3): 389-406.
    • (2015) Microarrays , vol.4 , Issue.3 , pp. 389-406
    • Walsh, C.1    Hu, P.2    Batt, J.3
  • 20
    • 84922311029 scopus 로고    scopus 로고
    • Developing a clinically feasible personalized medicine approach to pediatric septic shock
    • Wong HR, Cvijanovich NZ, Anas N, et al. Developing a clinically feasible personalized medicine approach to pediatric septic shock. Am J Respir Crit Care Med. 2015; 191 (3): 309-315.
    • (2015) Am J Respir Crit Care Med , vol.191 , Issue.3 , pp. 309-315
    • Wong, H.R.1    Cvijanovich, N.Z.2    Anas, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.